Come and hear from our CEO @drbrad69 why MiCheck® Prostate is such a great tool in the #prostatecancer journey.
Minomic's presentation will take place at 4pm at 8 Hadenfeld Rd, Macquarie Park.
Free tickets are here: https://t.co/3NLYYXWMoV
#deeptech
MiCheck Prostate, a non-invasive prostate cancer test developed in Australia as part of a collaborative project between @MinomicInt & @AMGC_Ltd has been successfully commercialised.
#project#manufacturing#australia#medical#prostatecancer
https://t.co/IwinEyKNrv
We had the opportunity to share Minomic’s journey from genesis of the company to launch of MiCheck® Prostate in the US market with @360DxNews, a leading media outlet for the #diagnostics industry.
Subscribe to 360Dx to read the full article: https://t.co/0VQAlBPOqq
The number of men being diagnosed with #ProstateCancer is expected to increase by as much as 43% between now and 2040. Early and accurate diagnosis is key to boosting survival rates. MiCheck® Prostate is designed to better-detect aggressive prostate cancer.
Implementing risk-stratified screening, such as biomarkers, minimizes overdiagnosis and avoids #biopsy in men with low-risk prostate cancer while addressing the rising trends of high-grade and #metastatic#ProstateCancer.
https://t.co/atr3xZL7PR
Unprecedented improvements in the survival of men with #Advanced#ProstateCancer thanks to the access to therapies approved over the last decade
https://t.co/FFoP1EQMtP
Minomic is pleased to be part of the Australian Government vision to build sovereign capability. Read more: https://t.co/hMDiPww0R2
#ProstateCancer#Investment#MedTech
According to Dr @LoebStacy, younger men who consume healthy #plantbased foods, dramatically lower their risk of developing advanced #ProstateCancer
https://t.co/MT7H0i6mQo
We are pleased to welcome @DrSiddireddy who has joined us as the key postdoctoral researcher overseeing our @micheck_test clinical studies at @Macquarie_Uni Hospital. She is the recipient of STEM+ Business Fellowship from @CSIRO in partnership with Minomic and @MQMedicalSchool
#Plantbased diets are associated with a decreased risk of #erectile dysfunction, lower #PSA rates, and possibly a lower rate of total and fatal #ProstateCancer among younger men.
https://t.co/Fly7sURn3y
Minomic is thrilled to cooperate with the #CLIAx team that allows us to tap into the expertise in laboratory testing. It is a ‘soft landing’ site to enter the U.S. market for MiCheck Prostate test rollout. https://t.co/CvNt3jKhRc
These findings highlight the importance of considering mental wellbeing during follow-up for early recognition and treatment of #ProstateCancer
https://t.co/oe3iF2rYh6
You are invited to the webinar where @drbrad69 shares the story of @micheck_test development and the current activities in rolling the test out in Australia, the US and China. Register to participate in the event or to get a recording: https://t.co/LPgl4heUln
@HBSAlumni